Get 25% discount on our yearly plans! Subscribe now

CLVRW by TradingView
Key Metrics
Market Cap
Total Shares Outstanding
Book Value
PE Ratio
PS Ratio
PB Ratio
Forward PE Ratio
ROIC
Return on Aseets
Return on Equity
Dividend
Dividend Yield
Balancesheet Metrics
Total Assets 31.24M
Total Liability 7.03M
Assets-to-Libability Ratio 4.45
Total Current Assets 13.94M
Total Current Liability 5.81M
Current Ratio 2.4
Quick Ratio 1.63
Debt to Equity Ratio -
Income Statement Metrics
Net Income
EPS
EBITA
Gross Profit
Gross Profit Margin
Operating Margin
Net Profit Margin
Price Metrics
5 Days MA
10 Days MA
20 Days MA
50 Days MA
200 Days MA
52 Weeks High
52 Weeks low
All Time High
RSI
MACD
Share Stats
Shares Float
Shares Short
% Short
% Insider
% Institutions
News

Profile

Clever Leaves Holdings Inc (CLVRW)

Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industries. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment cultivates, extracts, manufactures, commercializes, and distributes cannabinoid products comprising cannabis flowers, cannabidiol isolates, full spectrum and standardized extracts, and dry smokable flowers internationally. The Non-Cannabinoid segment formulates, manufactures, markets, sells, distributes, and commercializes nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. It also produces extracted products, including isolates, crude oil extracts, and oral solutions; and tetrahydrocannabinol flowers. The company serves retail distributors, pharmaceutical and cannabis companies, and pharmacies. Clever Leaves Holdings Inc. was founded in 2017 and is based in Tocancipá, Colombia.

Exchange: NASDAQ

IPO Date: 12/18/2020

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 296

Address: Bodega 19-B, Parque Industrial Tibitoc P.H, Tocancipá, Colombia, 251017

https://cleverleaves.com

&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;03/31/202412/31/202309/30/202306/30/202303/31/202312/31/202209/30/202206/30/202203/31/202212/31/2021Totals
Assets
31.24K31.24K37.78K42.83K46.24K52.10K81.42K105.46K127.22K116.16K1.29M
Current Assets
13.94K13.94K17.93K18.41K21.13K26.25K40.55K44.27K69.16K60.39K663.13K
Cash And Short Term Investments
6.90K-6.47K5.08K6.36K12.45K17.18K19.02K44.31K37.23K417.16K
Net Receivables
2.08K9072.83K4.59K4.79K4.32K4.64K5.87K5.38K4.62K50.84K
Inventory
4.48K4.48K7.71K7.47K8.02K8.40K16.65K16.74K16.23K15.41K153.18K
Other Current Assets
477-2.01K3.27K4.11K3.15K4.12K2.63K3.23K3.14K38.26K
Non Current Assets
17.30K17.30K19.84K24.42K25.11K25.85K40.87K61.20K58.06K55.77K628.01K
Property Plant Equipment
---13.09K13.49K-29.00K29.50K30.06K30.93K257.46K
Long Term Investments
--1.90K5.78K5.75K5.68K5.41K5.75K1.39K1.46K39.25K
Non Currrent Assets Other
1.50K1.50K1.55K1.58K1.55K5254331.72K9.75K
Liabilities
7.03K7.03K8.09K8.88K9.47K11.69K11.91K20.87K44.77K43.39K400.67K
Current Liabilities
5.81K5.81K6.85K7.56K7.80K9.43K8.22K8.64K27.49K27.25K224.43K
Accounts Payable
2.06K2.06K2.09K2.30K1.78K2.30K2.34K3.23K4.37K3.98K41.49K
Short Long Term Debt
-49847747145746552052616.48K17.51K77.55K
Other Current Liabilities
2.84K-3.33K3.28K3.98K4.35K2.62K3.12K4.83K21.66K96.77K
Non Current Liabilities
1.21K1.22K1.24K1.32K1.66K2.26K3.70K12.23K17.27K16.14K94.83K
Long Term Debt
----------40.40K
Other Liabilities
-----------
Stockholder Equity
24.22K24.22K29.69K33.95K36.77K40.41K69.50K84.59K82.45K72.77K874.61K
Preferred Stock Equity
-----------
Liabilities And Stockholders Equity
31.24K-37.78K42.83K46.24K52.10K81.42K105.46K127.22K116.16K1.26M
Common Equity
-----------
Retained Earnings
----188.58K-184.99K--152.09K-131.93K-130.88K-114.74K-1.15M
Totals152.34K110.21K187.56K38.54K59.71K261.24K268.02K397.19K549.04K530.94K658.58K748.79K770.02K776.74K5.51M
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;12/31/202312/31/202212/31/202112/31/202012/31/2019Totals
Assets
31.24K52.10K116.16K165.88K95.72K461.10K
Current Assets
13.94K26.25K60.39K95.81K23.50K219.89K
Cash And Short Term Investments
6.90K12.45K37.23K79.46K12.04K148.08K
Net Receivables
2.08K4.32K7.29K6.16K1.60K21.44K
Inventory
4.48K8.40K15.41K10.19K5.42K43.90K
Other Current Assets
4773.15K4733.53K4.44K12.06K
Non Current Assets
17.30K25.85K55.77K70.07K72.22K241.21K
Property Plant Equipment
--30.93K25.68K-56.61K
Long Term Investments
-5.68K1.46K1.55K2.08K10.77K
Non Currrent Assets Other
1.50K6.70K26052668.58K
Liabilities
7.03K11.69K43.39K51.57K45.52K159.20K
Current Liabilities
5.81K9.43K27.25K10.16K6.10K58.74K
Accounts Payable
2.06K2.30K3.98K4.43K3.37K16.14K
Short Long Term Debt
49846517.51K880-19.35K
Other Current Liabilities
2.84K4.35K5.10K3.98K2.72K19.01K
Non Current Liabilities
1.21K2.26K16.14K41.40K39.43K100.45K
Long Term Debt
---33.84K-33.84K
Stockholder Equity
24.22K40.41K72.77K114.31K45.50K297.20K
Liabilities And Stockholders Equity
31.24K52.10K116.16K165.88K95.72K461.10K
Retained Earnings
---114.74K-69.01K--183.75K
Totals152.84K267.89K512.92K815.82K455.44K2.20M
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;06/30/202203/31/202212/31/202109/30/202106/30/202103/31/202112/31/202009/30/202006/30/2020Totals
Revenue
4.66K5.22K4.19K4.03K3.67K12.12K12.12K3.92K1.94K51.87K
Cost Of Revenue
3.35K3.19K5.99K1.50K1.34K4.70K4.70K1.84K1.03K27.65K
Gross Profit
1.30K2.04K-1.80K2.54K2.33K7.41K7.41K2.07K90724.22K
Operating Expenses
9.64K9.92K11.03K12.22K11.94K32.41K32.41K6.78K8.23K134.57K
Selling General Administrative
8.01K8.26K7.98K11.07K10.61K29.83K29.83K5.74K7.26K118.59K
Research Development
3594121.55K------2.32K
Other Operating Expenses
12.99K13.11K17.02K13.71K13.28K37.11K37.11K8.63K9.26K162.21K
Operating Income
-8.20K-11.89K-30.15K-9.68K-9.60K-7.32K-28.53K-4.71K-7.33K-117.41K
Net Interest Income
-652-2.12K-4.43K-485-920-978-1.46K-1.20K-953-13.21K
Interest Income
------1.74K-6.07K---7.80K
Interest Expense
6522.12K-4.43K485920-4.46K-4.46K1.20K953-7.01K
Other Income Expense Net
7.15K-4.18K7.16K10.69K661-29.35K8.14K-1.40K1.42K299
Income Before Tax
-1.05K-16.08K-22.99K1.01K-8.94K-36.67K-36.67K-6.11K-8.75K-136.25K
Tax Provision
------23.12--23.12
NetIncome
-1.05K-16.14K-24.00K995-8.96K-36.67K-36.67K-5.09K-8.01K-135.60K
NetIncome Applicable To Common Shares
-1.05K-16.14K-24.00K995-8.96K-13.77K-35.42K---98.34K
Ebit
-394-14.02K-22.99K1.48K-8.04K-41.13K-28.53K-3.89K-7.43K-124.94K
Basic EPS
----0.04-0.35-0.55-0.55-0.48-1.8900000000000001
Totals35.73K-36.30K-79.90K50.55K-669.96-48.51K-46.07K7.79K-1.45K-118.81K
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;12/31/202112/31/202012/31/2019Totals
Revenue
15.37K12.12K7.83K35.33K
Cost Of Revenue
14.15K4.70K4.73K23.59K
Gross Profit
1.22K7.41K3.10K11.74K
Operating Expenses
43.74K32.41K39.64K115.79K
Selling General Administrative
38.40K29.83K34.98K103.20K
Research Development
1.55K--1.55K
Other Operating Expenses
57.89K37.11K44.37K139.37K
Operating Income
-57.21K-28.53K-36.54K-122.28K
Net Interest Income
-6.82K-4.46K-2.68K-13.96K
Interest Income
--6.07K--6.07K
Interest Expense
-6.82K-4.46K2.68K-8.59K
Other Income Expense Net
12.53K-8.14K-9.34K-4.96K
Income Before Tax
-44.68K-36.67K-45.88K-127.24K
Tax Provision
950--950
NetIncome
-45.73K-36.67K-45.98K-128.38K
NetIncome Applicable To Common Shares
-45.73K-36.11K--81.84K
Ebit
-44.68K-41.13K-43.30K-129.11K
Basic EPS
--2.4-1.96-4.359999999999999
Totals-65.86K-78.66K-46.38K-190.91K
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;03/31/202412/31/202309/30/202306/30/202303/31/202312/31/202209/30/202206/30/202203/31/202212/31/2021Totals
Cash From Operating Activities
-1.54K-1.54K-2.20K-1.69K-6.08K-5.10K-5.38K-8.21K-10.37K-18.665-78.25K
Net Income
-5.11K-5.08K-5.14K-3.60K-4.08K-28.82K-20.16K-1.05K-16.14K-24.00K-207.26K
Depreciation
4324321.17K6196237379511.09K8962.48813.55K
Extraordinary Items
-----------
Change Receivables
---26-398-1.18K-482-509-816-2.03K
Change To Inventory
2.46K2.46K-503339263614-1.61K-1.79K-1.67K4.566-6.35K
Change To Liabilities
----358-1.79K--2.20K-1.22K-918161-11.26K
Change To Net Income
---388662-15.94K1.31K7.66K15.07K41.93K
ChangeToOperatingActivities
-----------
Cash flows From Investing Activities
----44-35--2552.11K-1.22K-1.33K-9.21K
Capital Expenditures
-156--108-44-35-1.05K-255-386-1.22K-3.548-9.52K
Other Cashflows From Investing Activities
----------1.17K
Cash From Financing Activities
-162-162760165-107-2503.89K-19.04K18.69K3.516154.18K
Net Borrowings
----175-82--232-19.04K-3.55K-24.12K-47.67K
Sale Purchase Of Stock
---340-25-4.12K-22.25K25.00K64.18K
Dividends Paid
-----------
Other Cashflows From Financing Activities
2.06K--76-98-2527.67K-16873-1.16K4.798207.41K
Cash And Cash Equivalents Changes
----1.57K-6.22K--1.75K-25.14K7.11K-8.49K-69.25K
Totals-2.03K-3.90K-6.09K-5.69K-17.32K-6.19K-5.95K-71.78K19.86K-18.53K-8.38K-36.43K111.68K126.17K-4.98K-29.02K205.5499999999999841.61K
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;12/31/202312/31/202212/31/202112/31/202012/31/201912/31/2018Totals
Cash From Operating Activities
-11.51K-29.07K-36.23K-21.96K-37.05K-94.52-135.91K
Net Income
-19.80K-66.17K-45.73K-36.67K-45.98K19.16-214.32K
Depreciation
2.85K3.67K3.51K3.59K1.48K-15.10K
Extraordinary Items
-------
Change Receivables
---1.84K-1.38K---3.22K
Change To Inventory
2.56K-4.45K-8.20K-4.77K-1.26K--16.13K
Change To Liabilities
---4.77K3.20K---1.57K
Change To Net Income
--15.97K11.59K--27.56K
ChangeToOperatingActivities
-------
Cash flows From Investing Activities
---7.28K-3.67K715.53-130.00K-140.23K
Capital Expenditures
-31-1.31K-7.28K-3.67K-18.68K--30.96K
Other Cashflows From Investing Activities
----715.53-130.00K-129.28K
Cash From Financing Activities
6563.29K1.83K91.84K62.83K131.02K291.47K
Net Borrowings
---24.59K6.54K---18.05K
Sale Purchase Of Stock
--26.42K-6.25K-131.57K151.75K
Dividends Paid
---10.75K--10.75K
Other Cashflows From Financing Activities
-199-1.27K26.95K95.01K34.88K-558.26154.82K
Cash And Cash Equivalents Changes
---41.68K66.21K--24.53K
Totals-25.48K-95.30K-102.91K210.35K-2.34K1.96K-13.72K